Proteomic alterations mediated by CKS1i in AML revealed key changes beyond S phase accumulation, with modulators of RAC1 and NADP/H activity significantly altered (Figure 5A, Supp. The gene discussed is RAC1; the disease is acute myeloid leukemia.